Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 14;30(2):63-67.
doi: 10.4103/meajo.meajo_173_21. eCollection 2023 Apr-Jun.

Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization

Affiliations

Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization

Surbhi Agrawal et al. Middle East Afr J Ophthalmol. .

Abstract

Purpose: The purpose of this study was to identify biomarkers that predict the response of treatment-naive idiopathic choroidal neovascularization (iCNV) to anti-VEGF treatment.

Methods: Fourteen eyes diagnosed with iCNV underwent a dilated fundus examination, Swept Source Optical Coherence Tomography (SS-OCT) and Optical Coherence Tomography - Angiography (OCT-A), and were given an anti-VEGF injection. The same examinations were repeated at every follow-up visit. Analysis of the pre- and posttreatment images was done to identify possible biomarkers which were evaluated to check association with decreased need for multiple anti-VEGF injections.

Results: At presentation, 11 patients showed a compact pattern, while three patients showed an arborizing pattern on OCT angiography (P = 1). On follow-up imaging, seven patients showed a marked response, five patients showed a moderate response, and two patients showed a mild response to anti-VEGF injection. Among the seven patients showing a marked response, only one required a repeat injection (P = 0.03). On analysis of SS-OCT, a novel Retinal Pigment Epithelium (RPE) healing response was observed in posttreatment imaging of six patients (P = 0.59).

Conclusion: A "marked" response to the first anti-VEGF injection results in a more sustained response and is a positive prognostic factor. RPE healing response is an interesting observation that merits further evaluation. Morphology of neovascular membranes has no effect on long-term need for multiple anti-VEGF injections.

Keywords: Anti-VEGF; OCT; OCT-A; biomarkers; idiopathic choroidal neovascularization.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Pre- and posttreatment images of four patients. All OCT-A images have been manually segmented to the level of the outer retina. Images in the subset show the B-scan segmentation level of respective OCT-A images. The two pairs of images on the left (A1-A2 and B1-B2) show compact morphology with marked resolution. Images C1-C2 show a large arborizing lesion with moderate response to anti-VEGF. Images D1-D2 also show an arborizing lesion with moderate response to anti-VEGF
Figure 2
Figure 2
Pre- and posttreatment images from four patients to illustrate the “RPE Healing” response. In all four posttreatment images, the SRHM appears to be covered by a distinct hyper-reflective membrane which is continuous with the RPE. In images A2, B2, and C2, this hyper-reflective membrane (red arrowhead) is continuous and fully covers the SRHM. Note that the membrane is of irregular thickness in A2, but has uniform thickness in B2 and C2. In image D2, this membrane (red arrowhead) is discontinuous and covers the SRHM only partially

Similar articles

References

    1. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103:1241–4. - PubMed
    1. Kang HM, Koh HJ. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Am J Ophthalmol. 2013;155:713–9. 719.e1. - PubMed
    1. Shi X, Wei W, Zhang C. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: A comparative study on visual acuity, retinal and choroidal thickness. Chin Med J (Engl) 2014;127:2279–85. - PubMed
    1. Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Long-term outcome and recurrence of idiopathic choroidal neovascularization treated with intravitreal bevacizumab. J Ocul Pharmacol Ther. 2016;32:431–6. - PubMed
    1. Zhou P, Yang L, Jin X. Ranibizumab versus bevacizumab for the treatment of idiopathic choroidal neovascularization:2-year results. Eur J Ophthalmol. 2016;26:262–7. - PubMed

MeSH terms

LinkOut - more resources